ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial

This study is currently recruiting participants.
Verified by Dynasplint Systems, Inc., July 2008

Sponsored by: Dynasplint Systems, Inc.
Information provided by: Dynasplint Systems, Inc.
ClinicalTrials.gov Identifier: NCT00717691
  Purpose

The purpose of this study is to regain range of motion of the great toe with dynamic splinting which will help reduce great toe's pain and swelling.


Condition Intervention
Hallux Limitus
Device: Metatarsophalangeal Extension Dynasplint System
Other: Standard of Care

MedlinePlus related topics:   Foot Health   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Single Group Assignment
Official Title:   Hallux Limitus Treated With Dynamic Splinting: A Randomized, Controlled Trial

Further study details as provided by Dynasplint Systems, Inc.:

Primary Outcome Measures:
  • Change in Active Range of Motion of Hallux (great toe) Extension [ Time Frame: Two Months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change in passive Range of Motion, Extension [ Time Frame: same ] [ Designated as safety issue: No ]

Estimated Enrollment:   50
Study Start Date:   July 2008
Estimated Study Completion Date:   December 2008
Estimated Primary Completion Date:   October 2008 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1: Experimental
Immediate fitting with dynamic splinting following diagnosis of hallux limitus.
Device: Metatarsophalangeal Extension Dynasplint System
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn for 30 minutes, three times per day, (while seated or resting in bed) totaling 1.5 hours per day.
Other: Standard of Care
The current standard of care in treating Hallux Limitus will be given to all patients regardless of randomized categorization, and this includes: analgesic and nonsteroidal anti-inflammatory drugs (NSAIDs), orthotics with medial stiffness, and reduction of great toe movement in motions such as kneeling or squatting with the toes in an extended position.
2: No Intervention
Control arm; patients only treated with standard of care following diagnosis of hallux limitus.
Other: Standard of Care
The current standard of care in treating Hallux Limitus will be given to all patients regardless of randomized categorization, and this includes: analgesic and nonsteroidal anti-inflammatory drugs (NSAIDs), orthotics with medial stiffness, and reduction of great toe movement in motions such as kneeling or squatting with the toes in an extended position.

Detailed Description:

Determine the efficacy of dynamic splinting in treating patients with hallux limitus, in a randomized, controlled trial.

  Eligibility
Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Reduced flexibility in AROM of extension in the great toe
  • Pain that is worsened by walking and/or squatting
  • Impaired gait pattern

Exclusion Criteria:

  • Metatarsal stress fracture
  • Interdigital neuroma
  • Sesamoid pathology
  • Gout
  • Metatarsalgia
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00717691

Contacts
Contact: Stanley R Kalish, DPM, FACFAS     770-477-9535     srkalish@bellsouth.net    
Contact: Buck Willis, PhD     866-720-1914     BWillis@dynasplint.com    

Locations
United States, Georgia
Atlanta Foot and Leg Clinic     Recruiting
      Jonesboro, Georgia, United States, 30236
      Contact: Stanley R Kalish, DPM, FACFAS     770-477-9535     SRKalish@bellsouth.net    
      Principal Investigator: Stanley R Kalish, DPM, FACFAS            
Ankle and Foot Centers, PC     Recruiting
      Marietta, Georgia, United States, 30066
      Contact: Mathew M John, DPM, FACFAS     770-977-3668     FootDoc@afcenters.com    
      Principal Investigator: Mathew M John, DPM, FACFAS            

Sponsors and Collaborators
Dynasplint Systems, Inc.

Investigators
Principal Investigator:     Stanley R Kalish, DPM, FACFAS     Atlanta Foot and Leg Clinic    
  More Information

Publications:
Goucher NR, Coughlin MJ. Hallux metatarsophalangeal joint arthrodesis using dome-shaped reamers and dorsal plate fixation: a prospective study. Foot Ankle Int. 2006 Nov;27(11):869-76.
 
Hockenbury RT. Forefoot problems in athletes. Med Sci Sports Exerc. 1999 Jul;31(7 Suppl):S448-58. Review.
 
Brodsky JW, Baum BS, Pollo FE, Mehta H. Prospective gait analysis in patients with first metatarsophalangeal joint arthrodesis for hallux rigidus. Foot Ankle Int. 2007 Feb;28(2):162-5.
 
Talarico LM, Vito GR, Goldstein L, Perler AD. Management of hallux limitus with distraction of the first metatarsophalangeal joint. J Am Podiatr Med Assoc. 2005 Mar-Apr;95(2):121-9.
 
Payne C, Chuter V, Miller K. Sensitivity and specificity of the functional hallux limitus test to predict foot function. J Am Podiatr Med Assoc. 2002 May;92(5):269-71.
 
Kennedy JG, Chow FY, Dines J, Gardner M, Bohne WH. Outcomes after interposition arthroplasty for treatment of hallux rigidus. Clin Orthop Relat Res. 2006 Apr;445:210-5.
 
DeFrino PF, Brodsky JW, Pollo FE, Crenshaw SJ, Beischer AD. First metatarsophalangeal arthrodesis: a clinical, pedobarographic and gait analysis study. Foot Ankle Int. 2002 Jun;23(6):496-502.
 
Canseco K, Long J, Marks R, Khazzam M, Harris G. Quantitative characterization of gait kinematics in patients with hallux rigidus using the Milwaukee foot model. J Orthop Res. 2008 Apr;26(4):419-27.
 
Lau JT, Daniels TR. Outcomes following cheilectomy and interpositional arthroplasty in hallux rigidus. Foot Ankle Int. 2001 Jun;22(6):462-70.
 

Responsible Party:   Dynasplint Systems, Inc. ( Buck Willis, PhD: Clinical Research Director )
Study ID Numbers:   2008.003
First Received:   July 15, 2008
Last Updated:   July 16, 2008
ClinicalTrials.gov Identifier:   NCT00717691
Health Authority:   United States: Institutional Review Board

Keywords provided by Dynasplint Systems, Inc.:
Hallux Limitus  
Dynamic Splinting  
Dynasplint  

Study placed in the following topic categories:
Musculoskeletal Diseases
Joint Diseases
Hallux Rigidus
Congenital Abnormalities
Foot Deformities
Hallux Limitus

Additional relevant MeSH terms:
Foot Deformities, Acquired

ClinicalTrials.gov processed this record on August 21, 2008




Links to all studies - primarily for crawlers